Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNN4 | O15554 | 4/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | CASP1 | P29466 | 1/20 | 0.43 |
| ▸ | CASP7 | P55210 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 5/20 | 0.36 |
| ▸ | KIF11 | P52732 | 1/20 | 0.35 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17251709 | 0.87 | KIF11 (0.45) | KCNN4ALOX15CYP3A4CASP1CASP7 | |
| SCHEMBL3132847 | 0.84 | KCNN4 (0.42) | KCNN4ALOX15CYP3A4CASP1CASP7 | |
| SCHEMBL572998 | 0.83 | KCNN4 (0.59) | KCNN4ALOX15CYP3A4CASP1CASP7 | |
| SCHEMBL7806575 | 0.80 | ALOX15 (0.43) | KCNN4ALOX15CYP3A4CASP1CASP7 | |
| SCHEMBL11043875 | 0.80 | ALOX15 (0.43) | KCNN4ALOX15CYP3A4CASP1CASP7 | |
| SCHEMBL10636658 | 0.79 | KCNN4 (0.42) | KCNN4ALOX15CYP3A4CASP1CASP7 | |
| SCHEMBL10510801 | 0.79 | KCNN4 (0.42) | KCNN4ALOX15CYP3A4CASP1CASP7 | |
| SCHEMBL30940020 | 0.78 | ALOX15 (0.41) | KCNN4ALOX15CYP3A4CASP1CASP7 | |
| SCHEMBL3751989 | 0.76 | CYP3A4 (0.45) | KCNN4ALOX15CYP3A4CASP1CASP7 | |
| SCHEMBL5409173 | 0.76 | CYP3A4 (0.39) | KCNN4ALOX15CYP3A4CASP1CASP7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-11029635-A | — | — | None | — | — | JP | disclosed |
| JP-10001461-A | — | — | None | — | — | JP | disclosed |
| CN-113754346-A | Radar stealth board surface damage repair material and repair method | 天诺光电材料股份有限公司 | 2021-12-07 | — | — | CN | disclosed |
| CN-111662432-A | Epoxy resin curing agent and preparation method and application thereof | 豆海娟 | 2020-09-15 | — | — | CN | disclosed |
| US-20110190535-A1 | PROCESS FOR PREPARING POLYAROMATIC POLYISOCYANATE COMPOSITIONS | HUNTSMAN INTERNATIONAL LLC (US) | 2011-08-04 | — | — | US | disclosed |
| US-7723460-B2 | Shape-memory resin performing remoldability and excellent in shape recovering property, and molded product composed of the cross-linked resin | NEC CORPORATION (JP) | 2010-05-25 | — | — | US | disclosed |
| EP-2183295-A1 | PROCESS FOR PREPARING POLYAROMATIC POLYISOCYANATE COMPOSITIONS | Huntsman International LLC (US) | 2010-05-12 | — | — | EP | disclosed |
| WO-2009024407-A1 | PROCESS FOR PREPARING POLYAROMATIC POLYISOCYANATE COMPOSITIONS | HUNTSMAN INTERNATIONAL LLC (US) | 2009-02-26 | — | — | WO | disclosed |
| US-20070148465-A1 | Shape-memory resin performing remoldability and excellent in shape recovering property, and molded product composed of the cross-linked resin | NEC CORPORATION (JP) | 2007-06-28 | — | — | US | disclosed |
| EP-0663929-B1 | AQUEOUS BINDER MIXTURE AND USE OF THE MIXTURE | BAYER AG (DE) | 2003-09-03 | — | — | EP | disclosed |
| EP-0158953-B1 | TRIAMINES, A PROCESS FOR THEIR PREPARATION AND THEIR USE AS CROSS-LINKING AGENTS OR HARDENERS FOR PLASTIC MATERIALS OR PRECURSERS HAVING EPOXY OR ISOCYANATE-GROUPS | BAYER AG (DE) | 1988-04-13 | — | — | EP | disclosed |
| EP-0162347-B1 | CYCLOALIPHATIC TRIISOCYANATES, PROCESS FOR THEIR PRODUCTION, AND THEIR USE IN THE MANUFACTURE OF POLYURETHANES | BAYER AG (DE) | 1987-12-09 | — | — | EP | disclosed |
| EP-0162346-B1 | TRIISOCYANATES, PROCESS FOR THEIR PRODUCTION, AND THEIR USE IN THE MANUFACTURE OF POLYURETHANES | BAYER AG (DE) | 1987-06-03 | — | — | EP | disclosed |
| US-4613687-A | POLYURETHANES | BAYER AKTIENGESELLSCHAFT (DE) | 1986-09-23 | — | — | US | disclosed |
| US-4603189-A | Triisocyanates and a process for their preparation | BAYER AKTIENGESELLSCHAFT (DE) | 1986-07-29 | — | — | US | disclosed |
| EP-0162346-A1 | Triisocyanates, process for their production, and their use in the manufacture of polyurethanes | BAYER AG (DE) | 1985-11-27 | — | — | EP | disclosed |
| EP-0162347-A1 | Cycloaliphatic triisocyanates, process for their production, and their use in the manufacture of polyurethanes | BAYER AG (DE) | 1985-11-27 | — | — | EP | disclosed |
| EP-0158952-A2 | Triamines, a process for their preparation and their use as cross-linking agents or hardeners for plastic materials or precursors having epoxy- or isocyanate-groups | BAYER AG (DE) | 1985-10-23 | — | — | EP | disclosed |
| EP-0158953-A2 | Triamines, a process for their preparation and their use as cross-linking agents or hardeners for plastic materials or precursers having epoxy or isocyanate-groups | BAYER AG (DE) | 1985-10-23 | — | — | EP | disclosed |
| EP-0046917-A1 | Polyisocyanate mixtures of the diphenylmethane class, as well as their use as synthesis components in the manufacture of polyurethanes by the isocyanate-polyaddition process | BAYER AG (DE) | 1982-03-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110190535-A1 | PROCESS FOR PREPARING POLYAROMATIC POLYISOCYANATE COMPOSITIONS | MAOA, DDC, MAOB | KCNN4 2891/4885ALOX15 2449/4885CYP3A4 322/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.